For: | Shu JZ, Huang YH, He XH, Liu FY, Liang QQ, Yong XT, Xie YF. Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression. World J Hepatol 2025; 17(3): 103854 [PMID: 40177201 DOI: 10.4254/wjh.v17.i3.103854] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v17/i3/103854.htm |
Number | Citing Articles |
1 |
Xing-Yu Luo, Wei-Bin Huang, Chuang-Hui Lu, Wu Gu, Zi-Xuan Feng, Sui Shen, Ming-Zheng Chen, Shu-Sen Zheng, Zhe Yang. Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspective. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1638372
|
2 |
Carlo Acierno, Fannia Barletta, Alfredo Caturano, Riccardo Nevola, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Luca Rinaldi. Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights. Nutrients 2025; 17(13): 2229 doi: 10.3390/nu17132229
|